Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders.
Year | Equity | Revenue | EBITDA | Fin. Res. | Net Inc. | Net Mar. | ROE | Cash | Debt | N.D. / EBITDA | OCF | CAPEX | FCF | Free | Div. |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
03/23 TTM | 374 | 520 | -162 | 10 | -146 | L | L | 403 | 61 | L | -56 | 0 | 7 | -56 | 0 |
The values above are represented in USD and the scale is in millions—10.000 is the equivalent of 10 billions. L inside the table means Loss.